These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34780359)

  • 41. Reply to "Mortality-related immune features and COVID-19".
    Cai L; Zhou X; Wang M; Mei H; Ai L; Mu S; Zhao X; Chen W; Hu Y; Wang H
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):1040-1041. PubMed ID: 33551029
    [No Abstract]   [Full Text] [Related]  

  • 42. From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
    Rubin R
    JAMA; 2024 Feb; 331(5):378-381. PubMed ID: 38198193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herd immunity in COVID-19: Needs de-emphasizing.
    Raina SK; Kumar R
    J Family Med Prim Care; 2022 May; 11(5):1595-1597. PubMed ID: 35800485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
    Flacco ME; Martellucci CA; Manzoli L
    Lancet; 2023 Sep; 402(10408):1129. PubMed ID: 37777328
    [No Abstract]   [Full Text] [Related]  

  • 45. [Contribution of GIGA I3 (GIGA-Infection, Immunity and Inflammation) to the understanding of the complex pathogen-host-environment interplay].
    Sadzot-Delvaux C
    Rev Med Liege; 2022 May; 77(5-6):256-257. PubMed ID: 35657179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concerns over functional experiments, interpretation, and required controls. Reply.
    Hsieh WC; Chen SY
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229733
    [No Abstract]   [Full Text] [Related]  

  • 47. Association between obesity and diabetes prevalence and COVID-19 mortality in Mexico: an ecological study.
    Noyola DE; Hermosillo-Arredondo N; Ramírez-Juárez C; Werge-Sánchez A
    J Infect Dev Ctries; 2021 Oct; 15(10):1396-1403. PubMed ID: 34780361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up.
    Salehi-Vaziri M; Pouriayevali MH; Fotouhi F; Jalali T; Banifazl M; Farahmand B; Sadat Larijani M; Ahmadi Z; Fereydouni Z; Tavakoli M; Karami A; Azad-Manjiri S; Yektay Sanati P; Dahmardeh S; Nemati AH; Sajadi M; Kashanian S; Ramezani A
    Microb Pathog; 2021 Dec; 161(Pt B):105296. PubMed ID: 34801646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural immune response and protection from SARS-CoV-2 reinfection.
    Margiotti K; Fabiani M; Mesoraca A; Giorlandino C
    Acta Virol; 2021; 65(4):333-338. PubMed ID: 34796710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.
    Peluso MJ; Donatelli J; Henrich TJ
    Transl Res; 2022 Mar; 241():1-12. PubMed ID: 34780969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 reinfection: the role of natural immunity, vaccines, and variants.
    Sciscent BY; Eisele CD; Ho L; King SD; Jain R; Golamari RR
    J Community Hosp Intern Med Perspect; 2021; 11(6):733-739. PubMed ID: 34804382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    Avci E; Abasiyanik F
    J Autoimmun; 2021 Dec; 125():102745. PubMed ID: 34781161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Web Exclusive. Annals for Hospitalists Inpatient Notes - Myocarditis After Vaccination for SARS-CoV-2.
    Dorfman AL; Murthy VL
    Ann Intern Med; 2021 Nov; 174(11):HO2-HO3. PubMed ID: 34781728
    [No Abstract]   [Full Text] [Related]  

  • 54. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
    Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
    CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status.
    Boschi C; Aherfi S; Houhamdi L; Colson P; Raoult D; Scola B
    Emerg Microbes Infect; 2021 Dec; 10(1):2276-2278. PubMed ID: 34792434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Not all fun and games: Potential incidence of SARS-CoV-2 infections during the Tokyo 2020 Olympic Games.
    Linton NM; Jung SM; Nishiura H
    Math Biosci Eng; 2021 Nov; 18(6):9685-9696. PubMed ID: 34814363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
    Naleway AL; Groom HC; Crawford PM; Salas SB; Henninger ML; Donald JL; Smith N; Thompson MG; Blanton LH; Bozio CH; Azziz-Baumgartner E
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(46):1608-1612. PubMed ID: 34793417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin.
    Al-Beltagi S; Goulding LV; Chang DKE; Mellits KH; Hayes CJ; Gershkovich P; Coleman CM; Chang KC
    Virulence; 2021 Dec; 12(1):2946-2956. PubMed ID: 34793280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].
    Kruglova LS; Pereverzina NO; Rudneva NS; Kamynina NN; Oynotkinova OS
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1381-1387. PubMed ID: 34792893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.